Community News

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued final written decisions on three additional Medtronic patents that Axonics is contesting. In March 2020, Axonics filed petitions with the PTAB requesting inter partes review (IPR) t

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Founder and CEO Joe Kiani has been appointed to President Biden's Council of Advisors on Science and Technology.

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--IV BioHoldings (IVBH) announces its public launch with three liquid biopsy companies that comprise eight clinical-ready diagnostics.

LOS ANGELES & BROOKLYN, N.Y.--(BUSINESS WIRE)--Innovative Health Diagnostics (IHD), empowering every person by providing access to accurate, clinical testing, when and where it matters most, announced today that it will open a new 4,000-square foot facility in Brooklyn, N.Y. The new lab is located at 20 Grand Ave., Suite 602, Brooklyn, N.Y. 11205, allowing IHD to further expand its services, which include fertility and in vitro fertilization (IVF) testing; FDA donor testing for families […]

IRVINE, Calif. & DENVER--(BUSINESS WIRE)-- #Bioscience--LA-based HATCHspaces® partners with Denver-based NexCore to deliver a purpose-built, turnkey wet lab facility for early stage life science companies.

IRVINE, Calif.--(BUSINESS WIRE)-- #biotech--CG Oncology and Roche to Collaborate on Trial of Oncolytic Immunotherapy CG0070 as Part of Novel Combination for Various Solid Tumor Indications

LOS ANGELES--(BUSINESS WIRE)--Alan Auerbach will present an overview of Puma Biotechnology at 8:00 a.m. EDT on Sept. 28, at the 2021 Cantor Virtual Global Healthcare Conference.

LONG BEACH, Calif.--(BUSINESS WIRE)--HydraFacial, a BeautyHealth Company, announced their first collaboration with Epicutis, a luxury skincare line.

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--jCyte, Inc., a private biotechnology company dedicated to improving the lives of patients with retinal degenerative diseases, announced today the continued expansion of the Company’s leadership team with the appointment of Dr. Rebecca Kammer as Vice President of Clinical Operations. In her new role, Dr. Kammer will be responsible for the leadership, oversight, and execution of clinical trials and studies to support the development of jCell for current […]

LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $NASDAQ #Biotechnology--PharmaCyte Biotech releases more positive results from the FDA required biocompatibility tests. The clinical trial capsules passed the tests.

MONROVIA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will present at the Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021 at 4:00 p.m. ET / 1:00 p.m. PT. A live webcast will be available under "Events & Presentations" in the Investors section of the Company's websit

LOS ANGELES--(BUSINESS WIRE)--OneLegacy Foundation Funded UCLA Clinical Trial Successfully Completes Kidney Transplant Without Lifetime of Immunosuppressive Drugs

COSTA MESA, Calif.--(BUSINESS WIRE)--Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announced that it has closed the Share Exchange Agreement with PKG, Inc. (PKG) thereby having total control and ownership of PKG, Inc. About Cerebain Biotech Corp. Cerebain Biotech Corp. (OTC: CBBT) is a development-stage medical device company focused on the creation and clinical development of a minimally invasive implantable device and a synthetic drug solution. The device […]

IRVINE, Calif.--(BUSINESS WIRE)--Hyperice, a global high-performance wellness brand specializing in percussion, dynamic air compression, vibration, thermal technology, mind technology, and contrast therapy, today announced a new partnership with UNINTERRUPTED, the Sports Emmy award winning athlete empowerment brand part of the media conglomerate built by NBA superstar LeBron James and his longtime business partner Maverick Carter, to launch an exclusive new content series: Staying In Rhythm. Pr

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that it has entered into a licensing agreement with Attillaps Holdings, Inc. under which Attillaps has granted Glaukos a global exclusive license to research, develop, manufacture and commercialize Attillaps’ proprietary library of investigational […]

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #nicotinamideriboside--ChromaDex Corp. (NASDAQ:CDXC) today announced findings from recently published preclinical studies, as well as recently registered clinical research, investigating Niagen® (patented nicotinamide riboside, or “NR”) in various health outcomes. Through the industry-leading ChromaDex External Research Program (CERP™), ChromaDex supplies Niagen® to researchers around the world at no cost to help advance the understanding of NR’s […]

GARDENA, Calif.--(BUSINESS WIRE)-- #bioCERTIFIED--New bioCERTIFIED™ Cleaning in Place (CIP) high purity solutions from Spectrum Chemical introduced at BioProcess International Conference, Boston.

LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $NASDAQ #Biotechnology--PharmaCyte Biotech announces positive results of one of the biocompatibility studies required by the FDA.

FOOTHILL RANCH, Calif.--(BUSINESS WIRE)--TAE Life Sciences today announced a partnership with BEC GmbH.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus releases ADMET Predictor 10.3 (APX.3) with key upgrades to its AIDD Module making it the premier program for AI-driven drug design.